1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events

Abstract

1,5-anhydroglucitol (1,5-AG) is a biomarker of acute hyperglycemia in diabetology and also in cardiodiabetology. It is used to monitor fluctuating glucose levels. 1,5-AG is a monosaccharide that is biochemically similar to D-glucose and originates from the nutrition. The presence of 1,5-AG in blood and tissue is nearly constant due to reabsorption in the renal proximal tubule. In acute hyperglycemia, renal reabsorption is inhibited by glucose and 1,5- AG is excreted in the urine, while its serum level decreases rapidly. 1,5-AG reflects glucose excursions over 1-3 days to 2 weeks. In this regard, low levels of serum 1,5-AG can be a clinical marker of short- term glycemic derangements such as postprandial hyperglycemia, which is an important risk factor for the pathogenesis of coronary artery disease (CAD) as low levels of 1,5-AG reflect severe plaque calcification in CAD and correlate with high-density lipoprotein cholesterol (HDL-C) levels. For these reasons, 1,5-AG may also be a marker for atherosclerosis; in fact an even better marker than HbA1c or fructosamine which are normally used. 1,5-AG may also be a predictor of cardiovascular disease, left ventricular dysfunction after acute coronary syndrome (ACS), and mortality after ACS. This articles reviews the current knowledge on 1,5-AG related to its use as predictor for cardiovascular events.

Effectiveness of Tea Made from <i>Cissampelos sympodialis</i> Leaves in the Treatment of Anxiety and Depression: A Controlled Clinical Trial

“…Myo-Inositol was associated with antidepressant activity in experimental models of depression and a possible role in stress resistance pathways evidenced in studies with plants 50,51 . The 1,5-Anhydroglucitol is an important substance with potential use for monitoring glycemic control, and may also interfere with cardiovascular risk 52 . Lastly, D-ribose is used as an anti-fatigue medication and appears to have a role in improving the quality and life expectancy of diabetic patients 53 .…”

Integration of omics technologies for the identification of predictive biomarkers in type 2 diabetes: a comprehensive analysis of recent literature

“…Metabolomics studies have shown that saliva 1,5-AG levels correlate with those in blood, inversely related to blood glucose levels. This makes saliva 1,5-AG a potential non-invasive biomarker for T2D diagnosis (Migała et al, 2022). In urine, metabolites such as 5′-MTA have shown significant changes in late-onset T2D compared to non-diabetic individuals, suggesting their potential as validated biomarkers for T2D.…”